{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:53:02Z","timestamp":1773021182995,"version":"3.50.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.critrevonc.2012.04.005","type":"journal-article","created":{"date-parts":[[2012,5,21]],"date-time":"2012-05-21T22:45:07Z","timestamp":1337640307000},"page":"350-360","source":"Crossref","is-referenced-by-count":3,"title":["Curcumin for monoclonal gammopathies. What can we hope for, what should we fear?"],"prefix":"10.1016","volume":"84","author":[{"given":"A.J.M.","family":"Vermorken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.J.M.","family":"Van de Ven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Andr\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2012.04.005_bib0005","series-title":"Phytopharmaceuticals in cancer chemoprevention","first-page":"349","article-title":"Curcumin derived from turmeric (Curcuma longa): a spice for all seasons","author":"Aggarwal","year":"2004"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.04.005_bib0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.fct.2011.10.070","article-title":"Effect on pro-inflammatory and antioxidant genes and bioavailable distribution of whole turmeric vs curcumin: similar root but different effects","volume":"50","author":"Martin","year":"2011","journal-title":"Food and Chemical Toxicology"},{"issue":"13","key":"10.1016\/j.critrevonc.2012.04.005_bib0015","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.critrevonc.2012.04.005_bib0020","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.04.005_bib0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11899-010-0047-9","article-title":"Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"5","author":"Kyle","year":"2010","journal-title":"Current Hematologic Malignancy Reports"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.04.005_bib0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2141.2001.02533.x","article-title":"Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance","volume":"112","author":"Gregersen","year":"2001","journal-title":"British Journal of Haematology"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.04.005_bib0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","article-title":"Monoclonal gammopathy of undetermined significance","volume":"134","author":"Kyle","year":"2006","journal-title":"British Journal of Haematology"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.04.005_bib0040","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.critrevonc.2012.04.005_bib0045","first-page":"578","article-title":"Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)","volume":"25","author":"Kyle","year":"2011","journal-title":"Oncology (Williston Park)"},{"issue":"11","key":"10.1016\/j.critrevonc.2012.04.005_bib0050","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","article-title":"Curcumin: from ancient medicine to current clinical trials","volume":"65","author":"Hatcher","year":"2008","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"20","key":"10.1016\/j.critrevonc.2012.04.005_bib0055","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","article-title":"Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance","volume":"10","author":"Sharma","year":"2004","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.critrevonc.2012.04.005_bib0060","first-page":"161","article-title":"The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias\/paraproteinemia","volume":"2","author":"Golombick","year":"2008","journal-title":"Biologics"},{"issue":"18","key":"10.1016\/j.critrevonc.2012.04.005_bib0065","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.1158\/1078-0432.CCR-08-2217","article-title":"The potential role of curcumin in patients with monoclonal gammopathy of undefined significance\u2014its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker","volume":"15","author":"Golombick","year":"2009","journal-title":"Clinical Cancer Research"},{"issue":"8","key":"10.1016\/j.critrevonc.2012.04.005_bib0070","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4065\/84.8.685","article-title":"Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients","volume":"84","author":"Bida","year":"2009","journal-title":"Mayo Clinic Proceedings"},{"issue":"11","key":"10.1016\/j.critrevonc.2012.04.005_bib0075","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1182\/blood.V87.11.4762.bloodjournal87114762","article-title":"Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies","volume":"87","author":"Bataille","year":"1996","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2012.04.005_bib0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ajh.23159","article-title":"Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: A randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study","volume":"87","author":"Golombick","year":"2012","journal-title":"American Journal of Hematology"},{"issue":"18","key":"10.1016\/j.critrevonc.2012.04.005_bib0085","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1182\/blood-2010-10-299487","article-title":"International Myeloma Workshop Consensus Panel 1.Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1","volume":"117","author":"Rajkumar","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2012.04.005_bib0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00062752-199801000-00008","article-title":"Interleukin-6 in multiple myeloma and related plasma cell dyscrasias","volume":"5","author":"Treon","year":"1998","journal-title":"Current Opinion in Hematology"},{"issue":"23","key":"10.1016\/j.critrevonc.2012.04.005_bib0095","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1158\/1078-0432.CCR-09-1483","article-title":"A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma","volume":"15","author":"Fulciniti","year":"2009","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"10.1016\/j.critrevonc.2012.04.005_bib0100","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S1016-8478(23)14027-1","article-title":"Curcumin inhibits osteoclastogenesis by decreasing receptor activator of nuclear factor-kappaB ligand (RANKL) in bone marrow stromal cells","volume":"26","author":"Oh","year":"2008","journal-title":"Molecules and Cells"},{"issue":"8","key":"10.1016\/j.critrevonc.2012.04.005_bib0105","first-page":"1167","article-title":"Myeloma bone disease and RANKL signaling","volume":"21","author":"Abe","year":"2011","journal-title":"Clinical Calcium"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.04.005_bib0110","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.4049\/jimmunol.173.6.3844","article-title":"IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation","volume":"173","author":"Park","year":"2004","journal-title":"Journal of Immunology"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.04.005_bib0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2141.1995.tb03296.x","article-title":"Diagnostic value of serum IL-6 level in monoclonal gammopathies","volume":"89","author":"DuVillard","year":"1995","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10.1016\/j.critrevonc.2012.04.005_bib0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2257.2003.00492.x","article-title":"The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma","volume":"25","author":"Alexandrakis","year":"2003","journal-title":"Clinical and Laboratory Haematology"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.04.005_bib0125","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.20.6.1625","article-title":"Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"20","author":"Cesana","year":"2002","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1016\/j.critrevonc.2012.04.005_bib0130","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/mnfr.201100440","article-title":"Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism","volume":"55","author":"Shin","year":"2011","journal-title":"Molecular Nutrition & Food Research"},{"issue":"8","key":"10.1016\/j.critrevonc.2012.04.005_bib0135","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood-2003-06-1984","article-title":"BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone","volume":"103","author":"Moreaux","year":"2004","journal-title":"Blood"},{"issue":"4\u20135","key":"10.1016\/j.critrevonc.2012.04.005_bib0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.clinbiochem.2008.10.024","article-title":"Correlation of expression levels of BLyS and its receptors with multiple myeloma","volume":"42","author":"Ju","year":"2009","journal-title":"Clinical Biochemistry"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.04.005_bib0145","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3816\/CLM.2006.n.046","article-title":"Targeting B-lymphocyte stimulator\/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies","volume":"7","author":"Shivakumar","year":"2006","journal-title":"Clinical Lymphoma Myeloma"},{"issue":"12","key":"10.1016\/j.critrevonc.2012.04.005_bib0150","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/rheumatology\/ker282","article-title":"Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study","volume":"50","author":"Eilertsen","year":"2011","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.critrevonc.2012.04.005_bib0155","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/art.24598","article-title":"Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: the Chingford study","volume":"60","author":"Livshits","year":"2009","journal-title":"Arthritis and Rheumatism"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.04.005_bib0160","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/ard.2008.090928","article-title":"Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus","volume":"68","author":"Morel","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"9","key":"10.1016\/j.critrevonc.2012.04.005_bib0165","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/1529-0131(200009)43:9<2100::AID-ANR22>3.0.CO;2-#","article-title":"Modulation of collagenase 3 in human osteoarthritic cartilage by activation of extracellular transforming growth factor beta: role of furin convertase","volume":"43","author":"Moldovan","year":"2000","journal-title":"Arthritis and Rheumatism"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.04.005_bib0170","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0961203307079045","article-title":"Monoclonal gammopathy in systemic lupus erythematosus","volume":"16","author":"Ali","year":"2007","journal-title":"Lupus"},{"issue":"24","key":"10.1016\/j.critrevonc.2012.04.005_bib0175","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1182\/blood-2011-04-347559","article-title":"Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study","volume":"118","author":"Lindqvist","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2012.04.005_bib0180","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejphar.2010.09.065","article-title":"Downregulation of B lymphocyte stimulator expression by curcumin in B lymphocyte via suppressing nuclear translocation of NF-kappaB","volume":"650","author":"Huang","year":"2011","journal-title":"European Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.04.005_bib0185","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.4049\/jimmunol.171.6.3194","article-title":"IL-6 induces NF-kappa B activation in the intestinal epithelia","volume":"171","author":"Wang","year":"2003","journal-title":"Journal of Immunology"},{"issue":"4","key":"10.1016\/j.critrevonc.2012.04.005_bib0190","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molcel.2010.07.023","article-title":"STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer","volume":"39","author":"Iliopoulos","year":"2010","journal-title":"Molecular Cell"},{"key":"10.1016\/j.critrevonc.2012.04.005_bib0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1752-0509-5-115","article-title":"Modeling the NF-kappaB mediated inflammatory response predicts cytokine waves in tissue","volume":"5","author":"Yde","year":"2011","journal-title":"BMC Systems Biology"},{"issue":"10","key":"10.1016\/j.critrevonc.2012.04.005_bib0200","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1373\/clinchem.2011.169433","article-title":"Polyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammation","volume":"57","author":"Hutchison","year":"2011","journal-title":"Clinical Chemistry"},{"issue":"1","key":"10.1016\/j.critrevonc.2012.04.005_bib0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/ard.2006.052159","article-title":"Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome","volume":"66","author":"Gottenberg","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1016\/j.critrevonc.2012.04.005_bib0210","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.intimp.2010.08.014","article-title":"Immunomodulatory and therapeutic activity of curcumin","volume":"11","author":"Srivastava","year":"2011","journal-title":"International Immunopharmacology"},{"issue":"12","key":"10.1016\/j.critrevonc.2012.04.005_bib0215","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/sj.leu.2402295","article-title":"Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications","volume":"15","author":"Gupta","year":"2001","journal-title":"Leukemia"},{"issue":"13","key":"10.1016\/j.critrevonc.2012.04.005_bib0220","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1158\/0008-5472.CAN-06-0190","article-title":"Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment","volume":"66","author":"Tai","year":"2006","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/j.critrevonc.2012.04.005_bib0225","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbrc.2008.07.051","article-title":"Curcumin prevents human dendritic cell response to immune stimulants","volume":"374","author":"Shirley","year":"2008","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.critrevonc.2012.04.005_bib0230","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ncomms1239","article-title":"Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer","volume":"2","author":"Haabeth","year":"2011","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/j.critrevonc.2012.04.005_bib0235","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/10428191003699563","article-title":"Dysregulation in T helper 1\/T helper 2 cytokine ratios in patients with multiple myeloma","volume":"51","author":"Sharma","year":"2010","journal-title":"Leukemia and Lymphoma"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.04.005_bib0240","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1582-4934.2007.00084.x","article-title":"Immunosuppression induced by immature dendritic cells is mediated by TGF-beta\/IL-10 double-positive CD4+ regulatory T cells","volume":"12","author":"Cools","year":"2008","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"5","key":"10.1016\/j.critrevonc.2012.04.005_bib0245","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1440-1711.2005.01371.x","article-title":"Dendritic cell dysfunction in cancer: a mechanism for immunosuppression","volume":"83","author":"Pinzon-Charry","year":"2005","journal-title":"Immunology and Cell Biology"},{"issue":"11","key":"10.1016\/j.critrevonc.2012.04.005_bib0250","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1002\/eji.200939052","article-title":"Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells","volume":"39","author":"Cong","year":"2009","journal-title":"European Journal of Immunology"},{"issue":"3","key":"10.1016\/j.critrevonc.2012.04.005_bib0255","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2249.2010.04232.x","article-title":"Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo","volume":"162","author":"Rogers","year":"2010","journal-title":"Clinical and Experimental Immunology"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.04.005_bib0260","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00262-011-1138-8","article-title":"Regulatory dendritic cells in the tumor immunoenvironment","volume":"61","author":"Shurin","year":"2012","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/j.critrevonc.2012.04.005_bib0265","doi-asserted-by":"crossref","first-page":"430394","DOI":"10.1155\/2011\/430394","article-title":"The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance","volume":"2011","author":"Janikashvili","year":"2011","journal-title":"Clinical and Developmental Immunology"},{"issue":"8","key":"10.1016\/j.critrevonc.2012.04.005_bib0270","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood-2006-03-011353","article-title":"Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients","volume":"108","author":"Banerjee","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.04.005_bib0275","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-3083.2010.02463.x","article-title":"Increased level of both CD4+FOXP3+regulatory T cells and CD14+HLA-DR\/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma","volume":"72","author":"Brimnes","year":"2010","journal-title":"Scandinavian Journal of Immunology"},{"issue":"3","key":"10.1016\/j.critrevonc.2012.04.005_bib0280","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/bjc.2011.575","article-title":"The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma","volume":"106","author":"Giannopoulos","year":"2012","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.04.005_bib0285","first-page":"054015","article-title":"Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study","author":"Kristinsson","year":"2011","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.critrevonc.2012.04.005_bib0290","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1634\/theoncologist.2007-0127","article-title":"Peripheral blood dendritic cell subsets from patients with monoclonal gammopathies show an abnormal distribution and are functionally impaired","volume":"13","author":"Martin-Ayuso","year":"2008","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.critrevonc.2012.04.005_bib0295","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.4049\/jimmunol.171.7.3863","article-title":"Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells","volume":"171","author":"Bharti","year":"2003","journal-title":"Journal of Immunology"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.04.005_bib0300","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3892\/etm_00000041","article-title":"Curcumin for the prevention of progression in monoclonal gammopathy of undetermined significance: a word of caution","volume":"1","author":"Vermorken","year":"2010","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"1","key":"10.1016\/j.critrevonc.2012.04.005_bib0305","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10875-011-9602-y","article-title":"TLR-mediated B cell defects and IFN-alpha in common variable immunodeficiency","volume":"32","author":"Yu","year":"2012","journal-title":"Journal of Clinical Immunology"},{"issue":"1","key":"10.1016\/j.critrevonc.2012.04.005_bib0310","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.intimp.2011.11.005","article-title":"Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression","volume":"12","author":"Tu","year":"2012","journal-title":"International Immunopharmacology"},{"issue":"1","key":"10.1016\/j.critrevonc.2012.04.005_bib0315","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00281-004-0193-z","article-title":"CD4 T cells in tumor immunity","volume":"27","author":"Gerloni","year":"2005","journal-title":"Springer Seminars in Immunopathology"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.04.005_bib0320","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1172\/JCI61034","article-title":"Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells","volume":"122","author":"Drobits","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"11","key":"10.1016\/j.critrevonc.2012.04.005_bib0325","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1084\/jem.20031030","article-title":"Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy","volume":"198","author":"Dhodapkar","year":"2003","journal-title":"Journal of Experimental Medicine"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.04.005_bib0330","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/intimm\/dxn035","article-title":"Osteoclasts support the survival of human plasma cells in vitro","volume":"20","author":"Geffroy-Luseau","year":"2008","journal-title":"International Immunology"},{"issue":"8","key":"10.1016\/j.critrevonc.2012.04.005_bib0335","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1084\/jem.20052136","article-title":"Enhancement of clonogenicity of human multiple myeloma by dendritic cells","volume":"203","author":"Kukreja","year":"2006","journal-title":"Journal of Experimental Medicine"},{"issue":"7","key":"10.1016\/j.critrevonc.2012.04.005_bib0340","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1634\/theoncologist.2010-0327","article-title":"Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?","volume":"16","author":"Tucci","year":"2011","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.critrevonc.2012.04.005_bib0345","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.exphem.2011.04.006","article-title":"Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro","volume":"39","author":"Tucci","year":"2011","journal-title":"Experimental Hematology"},{"issue":"11","key":"10.1016\/j.critrevonc.2012.04.005_bib0350","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/gut.2008.152496","article-title":"Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition","volume":"57","author":"Binion","year":"2008","journal-title":"Gut"},{"issue":"13","key":"10.1016\/j.critrevonc.2012.04.005_bib0355","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.3748\/wjg.14.2003","article-title":"Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice","volume":"14","author":"Yoysungnoen","year":"2008","journal-title":"World Journal of Gastroenterology"},{"issue":"4","key":"10.1016\/j.critrevonc.2012.04.005_bib0360","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0006-291X(02)02306-9","article-title":"Molecular mechanisms of anti-angiogenic effect of curcumin","volume":"297","author":"Gururaj","year":"2002","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.critrevonc.2012.04.005_bib0365","doi-asserted-by":"crossref","first-page":"281261","DOI":"10.1155\/2012\/281261","article-title":"Targeting the tumor microenvironment: focus on angiogenesis","volume":"2012","author":"Fan","year":"2012","journal-title":"Journal of Oncology"},{"issue":"3","key":"10.1016\/j.critrevonc.2012.04.005_bib0370","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","article-title":"Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis","volume":"15","author":"Paez-Ribes","year":"2009","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.critrevonc.2012.04.005_bib0375","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1517\/14712598.2011.623124","article-title":"Multifaceted roles of curcumin: two sides of a coin!","volume":"11","author":"Marathe","year":"2011","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"7","key":"10.1016\/j.critrevonc.2012.04.005_bib0380","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/ijc.24967","article-title":"The dark side of curcumin","volume":"126","author":"Burgos-Moron","year":"2010","journal-title":"International Journal of Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2012.04.005_bib0390","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3816\/CLML.2010.n.053","article-title":"Smoldering (asymptomatic) multiple myeloma: revisiting the clinical dilemma and looking into the future","volume":"10","author":"Waxman","year":"2010","journal-title":"Clinical Lymphoma Myeloma and Leukemia"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842812001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842812001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T18:25:02Z","timestamp":1713983102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842812001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1040842812001023"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2012.04.005","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}